Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease

Clin Mol Hepatol. 2019 Sep;25(3):331-332. doi: 10.3350/cmh.2019.0034. Epub 2019 May 30.

Authors

Dimitrios Patoulias¹, Konstantinos Imprialos¹, Konstantinos Stavropoulos¹, Michael Doumas^{1

2}

Affiliations

¹ Second Propedeutic Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
² Veterans Affairs Medical Center, The George Washington University, Washington, D.C., WA, USA.

No abstract available

Publication types

Letter
Comment

MeSH terms

Cardiovascular Diseases*
Humans
Leptin
Liver
Non-alcoholic Fatty Liver Disease*

Substances

Leptin